Share
Publications
-
14 June 2010 /Authorisation and supervision
-
22 July 2011 /Authorisation and supervision
Annual report 2010 of the Danish Medicines Agency's laboratory control activities
he drug regulatory authorities in Europe cooperate in a network called the Official Medicines Control Laboratories (OMCL). The Danish Medicines Agency has published an annual report for 2010 that describes the activities of the Agency to the OMCL network.
-
16 May 2013 /Authorisation and supervision
Annual report 2011 on laboratory control activities
The medical authorities in Europe cooperate in a network called the Official Medicines Control Laboratories (OMCL). The Danish Medicines Agency has published an annual report for 2011 that describes the activities of the Agency to the OMCL network.
-
15 November 2006 /Authorisation and supervision
Product defects and withdrawal of medicinal products in 2005
In 2005, there was almost the same number of reports on product defects as in 2004. The reports comprised both marketed and non-marketed medicinal products, including magistral medicinal products, which are manufactured according to a doctor's prescription.
-
26 July 2007 /Authorisation and supervision
Product defects and withdrawal of medicinal products in 2006
In 2006 there were more reports on product defects compared with 2005. The reports concerned both marketed and non-marketed medicinal products. including magistral medicinal products which are manufactured according to a doctor's directions.
-
19 May 2008 /Authorisation and supervision
Product defects and withdrawal of medicinal products in 2007
In 2007, 202 reports about medicinal product defects were registered, which is basically on level with 2006. 28 % of these reports resulted in a withdrawal from the Danish market, which is exactly the same proportion as the year before.
-
16 April 2009 /Authorisation and supervision
Product defects and withdrawal of medicinal products in 2008
In 2008, 177 reports of medicinal product defects were registered, which is less than in 2007. 23 % of these reports led to products being withdrawn from the market, which is also less than in the preceding years. Most of the withdrawals effected in 2008 were occasioned by reports made by the companies.
-
15 June 2010 /Authorisation and supervision
Product defects and withdrawal of medicinal products in 2009
In 2009, 186 reports of medicinal product defects were registered, which is slightly more than in 2008. Compared to 2008, the reporting sources and types of defects have shifted, and reports from the Danish Medicines Agency's own control system accounted for a larger share in 2009 compared to 2008.
-
12 September 2011 /Authorisation and supervision
Product defects and withdrawal of medicines 2010
In 2010, the Danish Medicines Agency received a total of 262 reports on product defects involving medicines. This is the highest number of reports received within the past five years.
-
26 November 2012 /Authorisation and supervision
Product defects and withdrawal of medicines 2011
In 2011, 356 reports of medicinal product defects were registered, which is the highest number ever. The majority of the reports came from companies and other authorities and predominantly concerned defects on the package and packaging material and deviations from specifications.
